(Q42910655)

11 November 2017

title

MRS study of the effects of minocycline on markers of neuronal and microglial integrity in ALS (English)

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

amyotrophic lateral sclerosis

10 July 2024

main subject

1 reference

1 reference

1 reference

Abdesslem Khiat

1

1 reference

11 November 2017

Monique D'Amour

2

1 reference

11 November 2017

Frédérique Souchon

3

1 reference

11 November 2017

Yvan Boulanger

4

1 reference

11 November 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20832222

10 July 2024

publication date

15 September 2010

1 reference

full work available at URL

11 November 2017

https://api.elsevier.com/content/article/PII:S0730725X10002304?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

https://api.elsevier.com/content/article/PII:S0730725X10002304?httpAccept=text/plain

10 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

Magnetic Resonance Imaging

10 July 2024

published in

1 reference

11 November 2017

volume

28

1 reference

11 November 2017

issue

10

1 reference

11 November 2017

page(s)

1456-1460

1 reference

Clinical potential of minocycline for neurodegenerative disorders

11 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis

10 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice

10 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

Minocycline treatment in acute stroke: an open-label, evaluator-blinded study.

10 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.

10 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

Minocycline for patients with ALS.

10 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

Interactions with GluR1 AMPA receptors could influence the therapeutic usefulness of minocycline in ALS.

10 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

ALS surrogate markers. MRS.

10 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

Detection of cerebral degeneration in amyotrophic lateral sclerosis using high-field magnetic resonance spectroscopy

10 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T.

10 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI.

10 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy

10 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis

10 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements

10 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

Magnetic resonance imaging and 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis

10 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

Brain metabolites in definite amyotrophic lateral sclerosis. A longitudinal proton magnetic resonance spectroscopy study

10 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

Rapid improvement in cortical neuronal integrity in amyotrophic lateral sclerosis detected by proton magnetic resonance spectroscopic imaging.

10 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy

10 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

Effect of creatine supplementation on metabolite levels in ALS motor cortices

10 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

Gabapentin therapy for amyotrophic lateral sclerosis: lack of improvement in neuronal integrity shown by MR spectroscopy

10 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

A prospective, randomized, placebo‐controlled evaluation of corticoneuronal response to intrathecal BDNF therapy in ALS using magnetic resonance spectroscopy: feasibility and results

10 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

10 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

Estimation of metabolite concentrations from localized in vivo proton NMR spectra

10 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis.

10 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings

10 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.MRI.2010.06.032

10 July 2024

Identifiers

1 reference

11 November 2017

1 reference